Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.
第一作者:
F,Berthold
第一单位:
Department of Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany. Electronic address: frank.berthold@uk-koeln.de.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);儿童(Child);儿童, 学龄前(Child, Preschool);无病生存(Disease-Free Survival);德国(Germany);人类(Humans);婴儿(Infant);神经母细胞瘤(Neuroblastoma);前瞻性研究(Prospective Studies);瑞士(Switzerland);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1016/j.annonc.2019.11.011
PMID
32067684
发布时间
2022-05-31
- 浏览4
Annals of oncology
422-429页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



